Evidence map›Paper›PMID 36161599›Full record

ArticleTurkish journal of medical sciences2022

Evaluation of clinical and laboratory findings in severe group COVID-19 pregnants without comorbidity.

Fatma Bozkurt, Ömer Çoşkun, Sevda Yeleç, Muhammed Bekçibaşı, Muhammet Asena, İhsan Bağlı

Open access · bronzeAbstract read
In one paragraph

Article in Turkish journal of medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Predictors of COVID-19 severity among pregnant patients.Bosnian journal of basic medical sciences · 2022
    Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 4 countries.

Fatma BozkurtDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, University of Health Science,Gazi Yaşargil Education and Research Hospital, Diyarbakır, Turkey.
Ömer ÇoşkunDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, University of Health Science, Gazi Yaşargil Education and Research Hospital, Diyarbakır, Turkey.
Sevda YeleçDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Health Science, Gazi Yaşargil Education and Research Hospital, Diyarbakır, Turkey.
Muhammed BekçibaşıDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Bismil State Hospital, Diyarbakır, Turkey.
Muhammet AsenaDepartment of Child Health And Diseases, Faculty of Medicine, University of Health Science, Gazi Yaşargil Education and Research Hospital, Diyarbakır, Turkey.
İhsan BağlıDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Health Science, Gazi Yaşargil Education and Research Hospital, Diyarbakır, Turkey.
Sağlık Bilimleri Üniversitesi · TRState Hospital · GBUniversity of Health Science · KH

Funding

NIH HHS RO1DK561234
6 · The paper itself

Abstract

backgroundCOVID - 19 disease may be seen with different clinical presentations in pregnant women. Comorbid diseases are important factors affecting the progression of this disease. In this study, we aimed to evaluate the clinical and laboratory findings in pregnant women with COVID - 19 who had no comorbid disease.

methodsThis retrospective designed study included 217 patients with Covid PCR positive in typically COVID - 19 clinic. The patients were classified into asymptomatic, nonsevere, and severe disease groups. The symptoms, laboratory results, hospital followups and intensive care records of the patients and the findings of new borns are presented.

resultsMost of the patients (78%) were in the third trimester of pregnancy, and 103 patients in the study group had severe disease. Fever in the non-severe group and respiratory distress in the severe group were the most common symptoms in the patients. The severe clinical manifestations were specifically observed in the third trimester patients. In the severe group, neutrophil, lactat dehydrogenase, ferritin, CK - MB, IL - 6, and hospital stay were statistically higher than those in other groups (p < 0.05). Increase in BUN and creatine were the most predictive parameters in intensive care admission. While the intensive care unit (ICU) requirement was higher in patients in the severe group, premature birth was observed more frequently in the severe group (p < 0.05) .

Indexed as

COVID-19ComorbidityCreatineFemaleFerritinsHumansOxidoreductasesPregnancyRetrospective StudiesSARS-CoV-2CreatineFerritinsOxidoreductases3rd trimesterCOVID-19ferritinpregnancysevere disease

Identifiers

PMID36161599
PMCPMC10734852
OpenAlexW3182811762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.